FindTrial
Sign In

A study on patients to compare the effect of satranidazole and ornidazole medicine in the treatment of gum disease

Comparative evaluation of the clinical efficacy of 3% Satranidazole and 1% Ornidazole in the treatment of chronic periodontitis.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/06/019522
Enrollment
16
Registered
2019-06-04
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K053- Chronic periodontitis

Interventions

Intervention1: Satranidazole drug: 3% satranidazole gel for 28 days Control Intervention1: Ornigreat gel: 1% ornidazole gel for 28 days

Sponsors

P Bhavana
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with mild to moderate periodontitis according to AAP guidelines, 1999. 2. Minimum of 20 teeth in the mouth 3. Age range of 25-65 years. 4. Patients who have not received periodontal treatment for past 6 months to 1 year.

Exclusion criteria

Exclusion criteria: 1. Patients with uncontrolled systemic diseases. 2. Patients with aggressive periodontitis.

Design outcomes

Primary

MeasureTime frame
Probing pocket depth less than 3mmTimepoint: Probing pocket depth less than 3mm - 28days—

Secondary

MeasureTime frame
1.Bleeding index 2.Plaque index 3.Gingival index 4.Clinical attachment levelTimepoint: 1.Bleeding index - 28days 2.Plaque index - 28days 3.Gingival index - 28days 4.Clinical attachment level- 28days—

Countries

India

Contacts

Public ContactDr P Bhavana

VISHNU DENTAL COLLEGE

bhavanaparimisetti@gmail.com9542979929

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026